Advanced Therapies Europe 2022

  The Advanced Therapies Europe 2022 conference focused on exploring the commercialization of advanced therapy medicinal products (ATMPs), with talks on patient access, the manufacturing chain, and clinical case studies of cell and gene therapies. The event targeted Europeans looking for global growth as well as the global audience aiming to expand into the European […]

Advanced Therapies Congress, 24-25 May, 2022, ExCel, London

On the 24th of May, 2022, PMM team members, Xuanqi Song and Sam Jarada, attended the Advanced Therapies Congress held at the London ExCeL. The Advanced Therapies Congress explored, defined, and attempted to tackle the main challenges currently being faced when it comes to the development of patient access to advanced therapy medicinal products (ATMP). […]

Advanced Therapies Congress & Expo 2021

On the 5th of October, 2021, PMM team members Celeste Cohen, Shannon Hylton, and Aaron Logsdon attended the Advanced Therapies Congress held at the London ExCeL. The Advanced Therapies Congress explored, defined, and attempted to tackle the main challenges currently being faced when it comes to the development of patient access to advanced therapy medicinal products […]

Huntington’s disease: prevention and current innovations in treatment

Huntington’s disease: prevention and current innovations in treatment Jenny ChatzigerouHuntington’s disease (HD) is a genetic neurodegenerative disorder that was first described in 1872 by the physician George Huntington,1 in his seminal paper ‘On Chorea’.  Huntington described the condition as a hereditary, progressive, adult-onset disease that caused patients to suffer from a range of cognitive, motor, […]